Epilepsy and epileptic syndrome

Advances in Experimental Medicine and Biology

Volumn 724, Issue , 2012, Pages 99-113

  Ono, Tomonori ^a   Galanopoulou, Aristea S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ASCORBIC ACID; BIOLOGICAL MARKER; ETHOSUXIMIDE; ETIRACETAM; PHENOBARBITAL; RAPAMYCIN; VALPROIC ACID; ZONISAMIDE;

ARTICLE; CELL LOSS; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE ACTIVITY; DISEASE MARKER; DRUG MECHANISM; DRUG TARGETING; ELECTROCORTICOGRAPHY; EPILEPSY; EPILEPTOGENESIS; GABAERGIC SYSTEM; GENE EXPRESSION PROFILING; GLIOSIS; HIPPOCAMPAL SCLEROSIS; HUMAN; KETOGENIC DIET; MEMORY DISORDER; MOLECULAR PATHOLOGY; NERVE CELL NETWORK; NERVE DEGENERATION; NERVE INJURY; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SYNAPTIC TRANSMISSION; TEMPORAL LOBE EPILEPSY; TRAUMATIC EPILEPSY; TREATMENT RESPONSE; DEGENERATIVE DISEASE; DISEASE COURSE; REVIEW;

COGNITION DISORDERS; DISEASE PROGRESSION; EPILEPSY; HUMANS; NEURODEGENERATIVE DISEASES;

EID: 84859487568     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0653-2_8     Document Type: Article

References (165)

1. Hirtz D, Thurman DJ, Gwinn-Hardy K et al. How common are the "common" neurologic disorders? Neurology 2007; 68:326-337.
2. WHO. Epilepsy. Fact Sheet 2009. http://www.who.int/mediacentre/ factsheets/fs999/en/index.html
3. Fisher RS, van Emde Boas W, Blume W et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005; 46:470-472.
4. Engel J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001; 42:796-803.
5. Engel JJr. Do we belittle epilepsy by calling it a disorder rather than a disease? Epilepsia 2010; 51:2363-2364.
6. Pitkanen A. Therapeutic approaches to epileptogenesis-hope on the horizon. Epilepsia 2010; 51 Suppl 3:2-17.
7. Berg AT, Berkovic SF, Brodie MJ et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010; 51:676-685.
8. Escayg A, Goldin AL. Sodium channel SCN1A and epilepsy: mutations and mechanisms. Epilepsia 2010; 51:1650-1658.
9. Galanopoulou AS. Dissociated gender-specific effects of recurrent seizures on GABA signaling in CA1 pyramidal neurons: role of GABA(A) receptors. JNeurosci 2008; 28:1557-1567.
10. Macdonald RL, Kang JQ, Gallagher MJ. Mutations in GABAA receptor subunits associated with genetic epilepsies. J Physiol 2010; 588:1861-1869.
11. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30:389-399.
12. Kwan P, Brodie MJ. Early identification ofrefractory epilepsy. N Engl J Med 2000; 342:314-319.
13. Brodie MJ. Diagnosing and predicting refractory epilepsy. Acta Neurol Scand Suppl 2005; 181:36-39.
14. French JA, Williamson PD, Thadani VM et al. Characteristics of medial temporal lobe epilepsy: I. Results ofhistory and physical examination. Ann Neurol 1993; 34:774-780.
15. Engel J Jr. Introduction to temporal lobe epilepsy. Epilepsy Res 1996; 26:141-150.
16. Engel J Jr. Mesial temporal lobe epilepsy: what have we learned? Neuroscientist 2001; 7:340-352.
17. Engel J. Natural history of mesial temporal lobe epilepsy with hippocampal sclerosis: how does kindling compare with other commonly usedanimalmodels? In: CorcoranME,MosheSL,eds. Kindling6. New York: Springer, 2005:371-384.
18. KwanP, Brodie MJ. Neuropsychological effectsof epilepsy andantiepilepticdrugs.Lancet2001; 357:216-222.
19. Motamedi G, Meador K. Epilepsy and cognition. Epilepsy Behav 2003; 4 Suppl 2:S25-S38.
20. Andersson-RoswallL,EngmanE, SamuelssonHetal. Cognitive outcome 10 years after temporal lobe epilepsy surgery: a prospective controlled study. Neurology 2010; 74:1977-1985.
21. Hermann B, Seidenberg M, Bell B et al. The neurodevelopmental impact of childhood-onset temporal lobe epilepsyonbrainstructureandfunction. Epilepsia 2002; 43:1062-1071.
22. O'Leary DS, Lovell MR, Sackellares JC et al. Effects of age of onset of partial and generalized seizures on neuropsychological performance in children. J Nerv Ment Dis 1983; 171:624-629.
23. Tassinari CA, Michelucci R, Forti A et al. The electrical status epilepticus syndrome. Epilepsy Res Suppl 1992; 6:111-115.
24. Galanopoulou AS, Bojko A, Lado F et al. The spectrum of neuropsychiatric abnormalities associated with electrical status epilepticus in sleep. Brain Dev 2000; 22:279-295.
25. McVicar KA, Shinnar S. Landau-Kleffner syndrome, electrical status epilepticus in slow wave sleep and language regression in children. Ment Retard Dev Disabil Res Rev 2004; 10:144-149.
26. Tassinari CA, Rubboli G. Cognition and paroxysmal EEG activities: from a single spike to electrical status epilepticus during sleep. Epilepsia 2006; 47 Suppl 2:40-43.
27. Hrachovy RA, Frost JD Jr. Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms/West syndrome). J ClinNeurophysiol 2003; 20:408-425.
28. Lombroso CT. A prospective study of infantile spasms: clinical and therapeutic correlations. Epilepsia 1983; 24:135-158.
29. Berg AT, Cross JH. Towards a modern classification of the epilepsies? Lancet Neurol 2010:9.
30. Partikian A, Mitchell WG. Neurodevelopmental and epilepsy outcomes in a North American cohort of patients with infantile spasms. J ChildNeurol 2010; 25:423-428.
31. PellockJM, Hrachovy R, Shinnar Setal. Infantile spasms: aUS consensus report. Epilepsia2010; 51:2175-2189.
32. KooB, Hwang PA, Logan WJ. Infantile spasms: outcome and prognostic factors of cryptogenic and symptomatic groups. Neurology 1993; 43:2322-2327.
33. Lux AL, Edwards SW, Hancock E et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol 2005; 4:712-717.
34. Primec ZR, Stare J, Neubauer D. The risk of lower mental outcome in infantile spasms increases after three weeks ofhypsarrhythmia duration. Epilepsia 2006; 47:2202-2205.
35. Kivity S, Lerman P, Ariel R et al. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia 2004; 45:255-262.
36. Darke K, Edwards SW, Hancock E et al. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial. Arch Dis Child 2010; 95:382-386.
37. Riikonen RS. Favourable prognostic factors with infantile spasms. Eur J PaediatrNeurol 2010; 14:13-18.
38. GiblinKA,BlumenfeldH.Isepilepsyapreventabledisorder? New evidence from animal models. Neuroscientist 2010; 16:253-275.
39. Naegele JR. Neuroprotective strategies to avert seizure-induced neurodegeneration in epilepsy. Epilepsia 2007; 48 Suppl 2:107-117.
40. Albala BJ, Moshe SL, Okada R. Kainic-acid-induced seizures: a developmental study. Brain Res 1984; 315:139-148.
41. Stafstrom CE, Thompson JL, Holmes GL. Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizures. Brain Res Dev Brain Res 1992; 65:227-236.
42. Galanopoulou AS, Vidaurre J, Moshe SL. Under what circumstances can seizures produce hippocampal injury: evidence for age-specific effects. Dev Neurosci 2002; 24:355-363.
43. GalanopoulouAS, AlmEM,VeliskovaJ.Estradiolreducesseizure- inducedhippocampalinjuryinovariectomized female but not in male rats. Neurosci Lett 2003; 342:201-205.
44. Raol YS, BudreckEC, Brooks-Kayal AR. Epilepsy after early-life seizures can be independent ofhippocampal injury.AnnNeurol2003; 53:503-511.
45. Shapiro LA, Wang L, Ribak CE. Rapid astrocyte and microglial activation following pilocarpine-induced seizures in rats. Epilepsia 2008; 49 Suppl 2:33-41.
46. Pitkanen A, Sutula TP. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol 2002; 1:173-181.
47. Vezzani A, Ravizza T, Balosso S et al. Glia as a source of cytokines: implications for neuronal excitability and survival. Epilepsia 2008; 49 Suppl 2:24-32.
48. de Lanerolle NC, Lee TS, Spencer DD. Astrocytes and epilepsy. Neurotherapeutics 2010; 7:424-438.
49. Yang T, Zhou D, Stefan H. Why mesial temporal lobe epilepsy with hippocampal sclerosis is progressive: uncontrolled inflammation drives disease progression? J Neurol Sci 2010; 296:1-6.
50. Wang YY, Smith P, Murphy M et al. Global expression profiling in epileptogenesis: does it add to the confusion? Brain Pathol 2010; 20:1-16.
51. Cavazos JE, Cross DJ. The role of synaptic reorganization in mesial temporal lobe epilepsy. Epilepsy Behav 2006; 8:483-493.
52. Boyett JM, Buckmaster PS. Somatostatin-immunoreactive interneurons contribute to lateral inhibitory circuits in the dentate gyrus of control and epileptic rats. Hippocampus 2001; 11:418-422.
53. Buckmaster PS, Dudek FE. In vivo intracellular analysis of granule cell axon reorganization in epileptic rats. J Neurophysiol 1999; 81:712-721.
54. Sutula T. Seizure-induced axonal sprouting: assessing connections between injury, local circuits and epileptogenesis. Epilepsy Curr 2002; 2:86-91.
55. Lopantsev V, Both M, Draguhn A. Rapid plasticity at inhibitory and excitatory synapses in the hippocampus induced by ictal epileptiform discharges. Eur J Neurosci 2009; 29:1153-1164.
56. Badawy RA, Harvey AS, Macdonell RA. Cortical hyperexcitability and epileptogenesis: understanding the mechanisms of epilepsy-part 2. J ClinNeurosci 2009; 16:485-500.
57. André VM, Cepeda C, Vinters HV et al. Interneurons, GABAA currents and subunit composition of the GABAA receptor intype I andtype II cortical dysplasia. Epilepsia 2010; 51(Suppl 3):166-170.
58. Cepeda C, André VM, Yamazaki I et al. Comparative study of cellular and synaptic abnormalities in brain tissue samples from pediatric tuberous sclerosis complex and cortical dysplasia type II. Epilepsia 2010; 51(Suppl3):160-165.
59. Rivera C, Voipio J, Thomas-Crusells J et al. Mechanism of activity-dependent downregulation of the neuron-specific K-Cl cotransporter KCC2. J Neurosci 2004; 24:4683-4691.
60. Brooks-Kayal AR, Raol YH, Russek SJ. Alteration of epileptogenesis genes. Neurotherapeutics 2009; 6:312-318.
61. Ben-Ari Y. Excitatory actions of gaba during development: the nature of the nurture. Nat Rev Neurosci 2002; 3:728-739.
62. Galanopoulou AS. GABA(A) receptors in normal development and seizures: friends or foes? Curr Neuropharmacol 2008; 6:1-20.
63. Rakhade SN, Jensen FE. Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol 2009; 5:380-391.
64. Knudsen EI. Sensitive periods in the development ofthe brain and behavior. JCogn Neurosci 2004;16:1412-1425.
65. Ben-Ari Y, Holmes GL. Effects of seizures on developmental processes in the immature brain. Lancet Neurol 2006; 5:1055-1063.
66. Sanchez RM, Koh S, Rio C et al. Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures. J Neurosci 2001; 21:8154-8163.
67. Zhang G, Raol YH, Hsu FC et al. Effects of status epilepticus on hippocampal GABAA receptors are age-dependent. Neuroscience 2004; 125:299-303.
68. Isaeva E, Isaev D, Khazipov R et al. Selective impairment of GABAergic synaptic transmission in the flurothyl model of neonatal seizures. EurJNeurosci 2006; 23:1559-1566.
69. Swann JW, Le JT, Lee CL. Recurrent seizures and the molecular maturation ofhippocampal and neocortical glutamatergic synapses. Dev Neurosci 2007; 29:168-178.
70. O'Reilly RC. Biologically based computational models ofhigh-level cognition. Science 2006; 314:91-94.
71. Veliskova J, Moshe SL. Sexual dimorphism and developmental regulation of substantia nigra function. Ann Neurol 2001; 50:596-601.
72. Galanopoulou AS, Moshe SL. The epileptic hypothesis: developmentally related arguments based on animal models. Epilepsia 2009; 50 Suppl 7:37-42.
73. Cancedda L, Fiumelli H, Chen K et al. Excitatory GABA action is essential for morphological maturation of cortical neurons in vivo. J Neurosci 2007; 27:5224-5235.
74. Wang DD, Kriegstein AR. GABA regulates excitatory synapse formation in the neocortex via NMDA receptor activation. J Neurosci 2008; 28:5547-5558.
75. MathernGW, BabbTL, Armstrong TM. Hippocampal sclerosis. Philadelphia: Lippincott-Raven, 1997:133-155.
76. ThomM, SisodiyaSM, Beckett Aetal. Cytoarchitecturalabnormalitiesinhippocampal sclerosis. JNeuropathol Exp Neurol 2002; 61:510-519.
77. Blumcke I, Zuschratter W, Schewe JC et al. Cellular pathology of hilar neurons in ammon's horn sclerosis. J Comp Neurol 1999; 414:437-453.
78. Kalviainen R, Salmenpera T, Partanen K et al. Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy. Neurology 1998; 50:1377-1382.
79. Theodore WH, Bhatia S, Hatta J et al. Hippocampal atrophy, epilepsy duration and febrile seizures in patients with partial seizures. Neurology 1999; 52:132-136.
80. Tasch E, Cendes F, Li LM et al. Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy. AnnNeurol 1999; 45:568-576.
81. Salmenpera T, Kalviainen R, Partanen K et al. Hippocampal and amygdaloid damage in partial epilepsy: a cross-sectional MRI study of241 patients. Epilepsy Res 2001; 46:69-82.
82. Cendes F, Andermann F, Gloor P et al. Atrophy of mesial structures in patients with temporal lobe epilepsy: cause or consequence ofrepeated seizures? AnnNeurol 1993; 34:795-801.
83. Spanaki MV, Kopylev L, Liow K et al. Relationship of seizure frequency to hippocampus volume and metabolism in temporal lobe epilepsy. Epilepsia 2000; 41:1227-1229.
84. Mathern GW, Adelson PD, Cahan LD et al. Hippocampal neuron damage in human epilepsy: Meyer's hypothesis revisited. Prog Brain Res 2002; 135:237-251.
85. Cavazos JE, Sutula TP. Progressive neuronal loss induced by kindling: a possible mechanism for mossy fiber synaptic reorganization and hippocampal sclerosis. Brain Res 1990; 527:1-6.
86. Cavazos JE, Das I, Sutula TP. Neuronal loss induced in limbic pathways by kindling: evidence for induction ofhippocampal sclerosis by repeated brief seizures. JNeurosci 1994; 14:3106-3121.
87. Bengzon J, Kokaia Z, Elmer E et al. Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci USA 1997; 94:10432-10437.
88. Pretel S, Applegate CD, Piekut D. Apoptotic and necrotic cell death following kindling induced seizures. Acta Histochem 1997; 99:71-79.
89. Kotloski R, Lynch M, Lauersdorf S et al. Repeated brief seizures induce progressive hippocampal neuron loss and memory deficits. Prog Brain Res 2002; 135:95-110.
90. Lowenstein DH. Epilepsy after head injury: an overview. Epilepsia 2009; 50 Suppl 2:4-9.
91. Agrawal A, Timothy J, Pandit L et al. Post-traumatic epilepsy: an overview. Clin Neurol Neurosurg 2006; 108:433-439.
92. Willmore LJ, Ueda Y. Posttraumatic epilepsy: hemorrhage, free radicals and the molecular regulation of glutamate. Neurochem Res 2009; 34:688-697.
93. Willmore LJ, Sypert GW, Munson JB. Recurrent seizures induced by cortical iron injection: a model of posttraumatic epilepsy. Ann Neurol 1978; 4:329-336.
94. Sharma V, Babu PP, Singh A et al. Iron-induced experimental cortical seizures: electroencephalographic mapping of seizure spread in the subcortical brain areas. Seizure 2007; 16:680-690.
95. Reilly PL. Brain injury: the pathophysiology of the first hours. 'Talk and die revisited'. J ClinNeurosci 2001; 8:398-403.
96. Thompson HJ, Lifshitz J, Marklund N et al. Lateral fluid percussion brain injury: a 15-year review and evaluation. J Neurotrauma 2005; 22:42-75.
97. PitkanenA, McIntosh TK. Animal models of posttraumatic epilepsy. JNeurotrauma 2006; 23:241-261.
98. PitkanenA, ImmonenRJ, GrohnOHet al. From traumatic brain injury to posttraumatic epilepsy: what animal models tell us about the process and treatment options. Epilepsia 2009; 50 Suppl 2:21-29.
99. Coulter DA, Rafiq A, Shumate M et al. Brain injury-induced enhanced limbic epileptogenesis: anatomical andphysiological parallels to an animalmodel of temporal lobe epilepsy. Epilepsy Res 1996; 26:81-91.
100. Reeves TM, Lyeth BG, Phillips LL et al. The effects of traumatic brain injury oninhibition in the hippocampus and dentate gyrus. Brain Res 1997; 757:119-132.
101. Mendez M, Lim G. Seizures in elderly patients with dementia: epidemiology and management. Drugs Aging 2003; 20:791-803.
102. Larner AJ. Epileptic seizures in AD patients. Neuromolecular Med 2010; 2010:71-77.
103. Minkeviciene R, Rheims S, Dobszay MB et al. Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci 2009; 29:3453-3462.
104. Palop JJ, Chin J, Roberson ED et al. Aberrant excitatory neuronal activity and compensatory remodeling ofinhibitory hippocampal circuits inmouse models of Alzheimer's disease. Neuron 2007; 55:697-711.
105. Roch C, Leroy C, Nehlig Aet al. Magnetic resonance imaging in the study of the lithium-pilocarpine model oftemporal lobe epilepsy in adult rats. Epilepsia 2002; 43:325-335.
106. Roch C, Leroy C, Nehlig A et al. Predictive value ofcortical injury for the development oftemporal lobe epilepsy in 21-day-old rats: an MRI approach using the lithium-pilocarpine model. Epilepsia 2002; 43:1129-1136.
107. Wieshmann UC, Woermann FG, Lemieux L et al. Development ofhippocampal atrophy: a serial magnetic resonance imaging study in a patient who developed epilepsy after generalized status epilepticus. Epilepsia 1997; 38:1238-1241.
108. VanLandingham KE, Heinz ER, Cavazos JE et al. Magnetic resonance imaging evidence ofhippocampal injury afterprolonged focal febrile convulsions. AnnNeurol 1998; 43:413-426.
109. Kuster GW, Braga-Neto P, Santos-Neto D et al. Hippocampal sclerosis and status epilepticus: cause or consequence? AMRI study. ArqNeuropsiquiatr 2007; 65:1101-1104.
110. Tokumitsu T, Mancuso A, Weinstein PR et al. Metabolic and pathological effects of temporal lobe epilepsy in rat brain detected by proton spectroscopy and imaging. Brain Res 1997; 744:57-67.
111. Connelly A, Van Paesschen W, Porter DA et al. Proton magnetic resonance spectroscopy in MRI-negative temporal lobe epilepsy. Neurology 1998; 51:61-66.
112. Woermann FG, McLean MA, Bartlett PA et al. Short echo time single-voxel 1H magnetic resonance spectroscopy in magnetic resonance imaging-negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis. Ann Neurol 1999; 45:369-376.
113. Shih JJ, Weisend MP, Lewine J et al. Areas of interictal spiking are associated with metabolic dysfunction in MRI-negative temporal lobe epilepsy. Epilepsia 2004; 45:223-229.
114. Gomes WA, Lado FA, de Lanerolle NC et al. Spectroscopic imaging of the pilocarpine model of human epilepsy suggests that early NAA reduction predicts epilepsy. Magn Reson Med 2007; 58:230-235.
115. Shen J, Zhang L, Tian X et al. Use of short echo time two-dimensional 1H-magnetic resonance spectroscopy in temporallobe epilepsy with negativemagneticresonance imaging findings. JIntMedRes2009; 37:1211-1219.
116. Rugg-GunnFJ, Eriksson SH, Symms MRet al. Diffusion tensor imaging of cryptogenic and acquired partial epilepsies. Brain 2001; 124:627-636.
117. Dube C, Yu H, Nalcioglu O et al. Serial MRI after experimental febrile seizures: altered T2 signal without neuronal death. Ann Neurol 2004; 56:709-714.
118. Nairismagi J, Grohn OH, Kettunen MI et al. Progression of brain damage after status epilepticus and its association with epileptogenesis: a quantitative MRI study in a rat model of temporal lobe epilepsy. Epilepsia 2004; 45:1024-1034.
119. Kim CH, Koo BB, Chung CK et al. Thalamic changes in temporal lobe epilepsy with and without hippocampal sclerosis: a diffusiontensor imaging study. Epilepsy Res 2010; 90:21-27.
120. Liacu D, de Marco G, Ducreux D et al. Diffusion tensor changes in epileptogenic hippocampus of TLE patients. Neurophysiol Clin 2010; 40:151-157.
121. Shon YM, Kim YI, Koo BB et al. Group-specific regional white matter abnormality revealed in diffusion tensor imaging ofmedial temporal lobe epilepsy without hippocampal sclerosis. Epilepsia2010; 51:529-535.
122. Mirrione MM, Schiffer WK, Siddiq M et al. PET imaging of glucose metabolism in a mouse model of temporal lobe epilepsy. Synapse 2006; 59:119-121.
123. JuppB, O'Brien TJ. Application of coregistration for imaging of animal models of epilepsy. Epilepsia 2007; 48 Suppl 4:82-89.
124. Goffin K, Van Paesschen W, Dupont P et al. Longitudinal microPET imaging of brain glucose metabolism in rat lithium-pilocarpine model of epilepsy. Exp Neurol 2009; 217:205-209.
125. Guo Y, Gao F, Wang S et al. In vivo mapping of temporospatial changes in glucose utilization in rat brain during epileptogenesis: an 18F- fluorodeoxyglucose-small animal positron emission tomography study. Neuroscience 2009; 162:972-979.
126. Shinnar S, Kang H, Berg AT et al. EEG abnormalities in children with a first unprovoked seizure. Epilepsia 1994; 35:471-476.
127. Shinnar S, Berg AT, Moshe SL et al. The risk of seizure recurrence after a first unprovoked afebrile seizure in childhood: an extended follow-up. Pediatrics 1996; 98:216-225.
128. Berg AT, Shinnar S, Levy SR et al. Early development of intractable epilepsy in children: a prospective study. Neurology 2001; 56:1445-1452.
129. Spooner CG, Berkovic SF, Mitchell LA et al. New-onset temporal lobe epilepsy in children: lesion on MRI predicts poor seizure outcome. Neurology 2006; 67:2147-2153.
130. NordHDR,MosheSL,ShinnarS.TheroleoffiEGinfebrile status epilepticus (FSE).BrainDev2010;32:37-41.
131. Shinnar S, Hesdorffer DC, Nordli DR Jr et al. Phenomenology of prolonged febrile seizures: results of the FEBSTAT study. Neurology 2008; 71:170-176.
132. Beume LA, Steinhoff BJ. Long-term outcome of difficult-to-treat epilepsy in childhood. Neuropediatrics 2010; 41:135-139.
133. Sutula TP, Hagen J, PitkanenA. Do epileptic seizures damage the brain? Curr OpinNeurol 2003; 16:189-195.
134. Gleissner U, Sassen R, Schramm J et al. Greater functional recovery after temporal lobe epilepsy surgery in children. Brain 2005; 128:2822-2829.
135. Jambaque I, Dellatolas G, Dulac O et al. Verbal and visual memory impairment in children with epilepsy. Neuropsychologia 1993; 31:1321-1337.
136. Elsharkawy AE, May T, Thorbecke R et al. Long-term outcome and determinants of quality of life after temporal lobe epilepsy surgery in adults. Epilepsy Res 2009; 86:191-199.
137. Jonas R, Nguyen S, HuB et al. Cerebral hemispherectomy: hospital course, seizure, developmental, language and motor outcomes. Neurology 2004; 62:1712-1721.
138. Tubbs RS, Nimjee SM, Oakes WJ. Long-term follow-up in children with functional hemispherectomy for Rasmussen's encephalitis. Childs Nerv Syst 2005; 21:461-465.
139. Bittigau P, Sifringer M, Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann N Y Acad Sci 2003; 993:103-114.
140. Dhanushkodi A, Shetty AK. Is exposure to enriched environment beneficial for functional post-lesional recovery intemporal lobe epilepsy? Neurosci Biobehav Rev 2008; 32:657-674.
141. Hamed SA. The multimodal prospects for neuroprotection and disease modification in epilepsy: relationship to its challenging neurobiology. Restor Neurol Neurosci 2010; 28:323-348.
142. Sutula T, Cavazos J, Golarai G. Alteration of long-lasting structural and functional effects of kainic acid in thehippocampusbybrieftreatmentwithphenobarbital. JNeurosci 1992; 12:4173-4187.
143. PitkanenA, KubovaH. Antiepileptic drugs in neuroprotection. Expert Opin Pharmacother 2004; 5:777-798.
144. Yan HD, Ji-qun C, Ishihara K et al. Separation of antiepileptogenic and antiseizure effects of levetiracetam inthe spontaneously epileptic rat (SER). Epilepsia 2005; 46:1170-1177.
145. Blumenfeld H, Klein JP, Schridde U et al. Early treatment suppresses the development of spike-wave epilepsy in a rat model. Epilepsia 2008; 49:400-409.
146. Muller-Schwarze AB, Tandon P, Liu Z et al. Ketogenic diet reduces spontaneous seizures and mossy fiber sproutinginthekainicacidmodel.Neuroreport 1999; 10:1517-1522.
147. Meyerhoff JL, Lee JK, Rittase BW et al. Lipoic acidpretreatment attenuates ferric chloride-induced seizures in the rat. Brain Res 2004; 1016:139-144.
148. Yokoi I, Toma J, Liu J et al. Adenosines scavenged hydroxyl radicals and prevented posttraumatic epilepsy. Free Radic Biol Med 1995; 19:473-479.
149. Kabuto H, Yokoi I, Ogawa N. Melatonin inhibits iron-induced epileptic discharges in rats by suppressing peroxidation. Epilepsia 1998; 39:237-243.
150. Miyamoto R, Shimakawa S, Suzuki S et al. Edaravone prevents kainic acid-induced neuronal death. Brain Res 2008; 1209:85-91.
151. Kamida T, Fujiki M, Ooba H et al. Neuroprotective effects of edaravone, a free radical scavenger, on the rat hippocampus after pilocarpine-induced status epilepticus. Seizure 2009; 18:71-75.
152. Komatsu M, Hiramatsu M, Willmore LJ. Zonisamide reduces the increase in 8-hydroxy-2'-deoxyguanosine levels formed during iron-induced epileptogenesis inthe brains of rats. Epilepsia 2000; 41:1091-1094.
153. Mori A, Yokoi I, Noda Y et al. Natural antioxidants may prevent posttraumatic epilepsy: a proposal based on experimental animal studies. Acta Med Okayama 2004; 58:111-118.
154. Guo X, Dawson VL, Dawson TM. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons. EurJNeurosci 2001; 13:1683-1693.
155. Chen CM, Lin JK, Liu SH et al. Novel regimen through combination of memantine and tea polyphenol for neuroprotection against brain excitotoxicity. J Neurosci Res 2008; 86:2696-2704.
156. Paradiso B, Marconi P, Zucchini S et al. Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model. Proc Natl Acad Sci USA 2009; 106:7191-7196.
157. Noe F, Nissinen J, Pitkanen A et al. Gene therapy in epilepsy: the focus onNPY. Peptides 2007; 28:377-383.
158. Moldrich RX, Chapman AG, De Sarro G et al. Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Eur J Pharmacol 2003; 476:3-16.
159. Elliott-Hunt CR, Kazlauskaite J, Wilde GJ et al. Potential signalling pathways underlying corticotrophin-releasing hormone-mediated neuroprotection from excitotoxicity inrat hippocampus. J Neurochem2002;80:416-425.
160. Napolioni V, Moavero R, Curatolo P. Recent advances in neurobiology of Tuberous Sclerosis Complex. Brain Dev 2009; 31:104-113.
161. Holmes GL, Stafstrom CE. Tuberous sclerosis complex and epilepsy: recent developments and future challenges. Epilepsia 2007; 48:617-630.
162. WongM. Mechanisms ofepileptogenesis in tuberous sclerosis complex and related malformations ofcortical development with abnormal glioneuronal proliferation. Epilepsia 2008; 49:8-21.
163. Zeng LH, Rensing NR, Wong M. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci 2009; 29:6964-6972.
164. Ljungberg MC, Sunnen CN, Lugo JN et al. Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia. Dis Model Mech 2009; 2:389-398.
165. Naegele JR, Maisano X, Yang J et al. Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy. Neuropharmacology 2010; 58:855-864.